PMC:1064873 / 7251-7473
Annnotations
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
15535835-3358796-4156884 | 80-82 | 3358796 | denotes | 25 |
biosemtest
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6850 | 115-127 | UMLS/C0032950 | denotes | ednisolone ( |
T6833 | 188-196 | UMLS/C1555900 | denotes | ical par |
T6831 | 68-79 | UMLS/C1704771 | denotes | sociation) |
T6829 | 68-79 | UMLS/C1704770 | denotes | sociation) |
T6828 | 197-207 | UMLS/C1704769 | denotes | meters in |
T6819 | 188-196 | UMLS/C1611832 | denotes | ical par |
T6811 | 91-99 | UMLS/C1705908 | denotes | tients w |
T6801 | 188-196 | UMLS/C1608518 | denotes | ical par |
T6791 | 215-220 | UMLS/C1705923 | denotes | y pat |
T6790 | 57-67 | UMLS/C0035435 | denotes | eumatism A |
T6788 | 188-196 | UMLS/C0205210 | denotes | ical par |
T6786 | 9-16 | UMLS/C0557806 | denotes | llege o |
T6784 | 20-32 | UMLS/C0035452 | denotes | eumatology ( |
T6776 | 48-56 | UMLS/C0596070 | denotes | erican R |
T6775 | 0-8 | UMLS/C0596070 | denotes | erican C |
T6769 | 197-207 | UMLS/C2350001 | denotes | meters in |
T6768 | 197-207 | UMLS/C0449381 | denotes | meters in |
T6753 | 91-99 | UMLS/C1550655 | denotes | tients w |
T6746 | 105-114 | UMLS/C1514756 | denotes | ceiving p |
T6738 | 215-220 | UMLS/C0557651 | denotes | y pat |
T6730 | 149-186 | UMLS/C0242708 | denotes | ase-modifying antirheumatic drugs. Cl |
T6717 | 20-32 | UMLS/C0334889 | denotes | eumatology ( |
T6704 | 68-79 | UMLS/C0699792 | denotes | sociation) |
T6703 | 215-220 | UMLS/C0008972 | denotes | y pat |
T6701 | 215-220 | UMLS/C0008976 | denotes | y pat |
T6691 | 137-143 | UMLS/C0439423 | denotes | ay) an |
T6688 | 137-143 | UMLS/C0439422 | denotes | ay) an |
T6684 | 215-220 | UMLS/C2603343 | denotes | y pat |
T6682 | 215-220 | UMLS/C2349977 | denotes | y pat |
T6673 | 91-99 | UMLS/C0030705 | denotes | tients w |
T6665 | 68-79 | UMLS/C0004083 | denotes | sociation) |
T6658 | 91-99 | UMLS/C1578479 | denotes | tients w |
T6649 | 91-99 | UMLS/C1578483 | denotes | tients w |
T6637 | 91-99 | UMLS/C1578480 | denotes | tients w |
T6628 | 91-99 | UMLS/C1578481 | denotes | tients w |
T6619 | 91-99 | UMLS/C1578486 | denotes | tients w |
T6610 | 91-99 | UMLS/C1578484 | denotes | tients w |
T6601 | 91-99 | UMLS/C1578485 | denotes | tients w |
T6597 | 105-114 | UMLS/C1709850 | denotes | ceiving p |
T6593 | 68-79 | UMLS/C0596306 | denotes | sociation) |
T6589 | 68-79 | UMLS/C0439849 | denotes | sociation) |
T6587 | 215-220 | UMLS/C1880229 | denotes | y pat |
T6566 | 197-207 | UMLS/C0549193 | denotes | meters in |
T6565 | 215-220 | UMLS/C0947630 | denotes | y pat |
pmc-enju-pas
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6946 | 211-216 | NN | denotes | study |
T6945 | 207-210 | DT | denotes | the |
T6944 | 204-206 | IN | denotes | in |
T6943 | 193-203 | NN | denotes | parameters |
T6942 | 184-192 | JJ | denotes | Clinical |
T6941 | 177-182 | NN | denotes | drugs |
T6940 | 163-176 | JJ | denotes | antirheumatic |
T6939 | 145-162 | JJ | denotes | disease-modifying |
T6938 | 141-144 | CC | denotes | and |
T6937 | 139-140 | -RRB- | denotes | ) |
T6936 | 133-139 | NN | denotes | mg/day |
T6935 | 129-132 | CD | denotes | 7.5 |
T6934 | 127-128 | SYM | denotes | ≤ |
T6933 | 126-127 | -LRB- | denotes | ( |
T6932 | 113-125 | NN | denotes | prednisolone |
T6931 | 103-112 | VB | denotes | receiving |
T6930 | 98-102 | VB | denotes | were |
T6929 | 89-97 | NN | denotes | patients |
T6928 | 85-88 | DT | denotes | All |
T6927 | 82-83 | -RRB- | denotes | ] |
T6926 | 80-82 | CD | denotes | 25 |
T6925 | 79-80 | -LRB- | denotes | [ |
T6924 | 77-78 | -RRB- | denotes | ) |
T6923 | 66-77 | NNP | denotes | Association |
T6922 | 55-65 | NNP | denotes | Rheumatism |
T6921 | 46-54 | NNP | denotes | American |
T6920 | 42-45 | DT | denotes | the |
T6919 | 40-41 | -COMMA- | denotes | , |
T6918 | 32-40 | RB | denotes | formally |
T6917 | 31-32 | -LRB- | denotes | ( |
T6916 | 18-30 | NNP | denotes | Rheumatology |
T6915 | 15-17 | IN | denotes | of |
T6914 | 7-14 | NNP | denotes | College |
R3236 | T6916 | T6915 | arg2Of | Rheumatology,of |
R3237 | T6916 | T6917 | arg1Of | Rheumatology,( |
R3238 | T6923 | T6917 | arg2Of | Association,( |
R3239 | T6923 | T6918 | arg1Of | Association,formally |
R3240 | T6923 | T6919 | arg1Of | Association,"," |
R3241 | T6923 | T6920 | arg1Of | Association,the |
R3242 | T6923 | T6921 | arg1Of | Association,American |
R3243 | T6923 | T6922 | arg1Of | Association,Rheumatism |
R3244 | T6924 | T6917 | arg3Of | ),( |
R3245 | T6926 | T6925 | arg2Of | 25,[ |
R3246 | T6927 | T6925 | arg3Of | ],[ |
R3247 | T6929 | T6928 | arg1Of | patients,All |
R3248 | T6929 | T6930 | arg1Of | patients,were |
R3249 | T6929 | T6931 | arg1Of | patients,receiving |
R3250 | T6931 | T6930 | arg2Of | receiving,were |
R3251 | T6932 | T6933 | arg1Of | prednisolone,( |
R3252 | T6932 | T6938 | arg1Of | prednisolone,and |
R3253 | T6935 | T6934 | arg1Of | 7.5,≤ |
R3254 | T6936 | T6933 | arg2Of | mg/day,( |
R3255 | T6936 | T6935 | arg1Of | mg/day,7.5 |
R3256 | T6937 | T6933 | arg3Of | ),( |
R3257 | T6938 | T6931 | arg2Of | and,receiving |
R3258 | T6941 | T6938 | arg2Of | drugs,and |
R3259 | T6941 | T6939 | arg1Of | drugs,disease-modifying |
R3260 | T6941 | T6940 | arg1Of | drugs,antirheumatic |
R3261 | T6943 | T6942 | arg1Of | parameters,Clinical |
R3262 | T6943 | T6944 | arg1Of | parameters,in |
R3264 | T6946 | T6944 | arg2Of | study,in |
R3265 | T6946 | T6945 | arg1Of | study,the |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6858 | 85-183 | Sentence | denotes | All patients were receiving prednisolone (≤ 7.5 mg/day) and disease-modifying antirheumatic drugs. |
T39 | 85-183 | Sentence | denotes | All patients were receiving prednisolone (≤ 7.5 mg/day) and disease-modifying antirheumatic drugs. |
ICD10
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6867 | 55-65 | http://purl.bioontology.org/ontology/ICD10/M79.0 | denotes | Rheumatism |
bionlp-st-ge-2016-test-ihmc
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T7310 | 145-182 | Entity | denotes | disease-modifying antirheumatic drugs |
T7307 | 113-140 | Entity | denotes | prednisolone (≤ 7.5 mg/day) |
bionlp-st-ge-2016-spacy-parsed
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T7156 | 211-216 | NN | denotes | study |
T7155 | 207-210 | DT | denotes | the |
T7154 | 204-206 | IN | denotes | in |
T7153 | 193-203 | NNS | denotes | parameters |
T7152 | 184-192 | JJ | denotes | Clinical |
T7151 | 182-183 | . | denotes | . |
T7150 | 177-182 | NNS | denotes | drugs |
T7149 | 163-176 | JJ | denotes | antirheumatic |
T7148 | 145-162 | JJ | denotes | disease-modifying |
T7147 | 141-144 | CC | denotes | and |
T7146 | 139-140 | -RRB- | denotes | ) |
T7145 | 133-139 | NN | denotes | mg/day |
T7144 | 129-132 | CD | denotes | 7.5 |
T7143 | 127-128 | CD | denotes | ≤ |
T7142 | 126-127 | -LRB- | denotes | ( |
T7141 | 113-125 | NN | denotes | prednisolone |
T7140 | 103-112 | VBG | denotes | receiving |
T7139 | 98-102 | VBD | denotes | were |
T7138 | 89-97 | NNS | denotes | patients |
T7137 | 85-88 | DT | denotes | All |
T7136 | 83-84 | . | denotes | . |
T7135 | 82-83 | NNP | denotes | ] |
T7134 | 80-82 | CD | denotes | 25 |
T7133 | 79-80 | NNP | denotes | [ |
T7132 | 77-78 | -RRB- | denotes | ) |
T7131 | 66-77 | NNP | denotes | Association |
T7130 | 55-65 | NNP | denotes | Rheumatism |
T7129 | 46-54 | JJ | denotes | American |
T7128 | 42-45 | DT | denotes | the |
T7127 | 40-41 | , | denotes | , |
T7126 | 32-40 | RB | denotes | formally |
T7125 | 31-32 | -LRB- | denotes | ( |
T7124 | 18-30 | NNP | denotes | Rheumatology |
T7123 | 15-17 | IN | denotes | of |
T7122 | 7-14 | NNP | denotes | College |
R3440 | T7123 | T7122 | prep | of,College |
R3441 | T7124 | T7123 | pobj | Rheumatology,of |
R3442 | T7125 | T7131 | punct | (,Association |
R3443 | T7126 | T7131 | advmod | formally,Association |
R3444 | T7127 | T7131 | punct | ",",Association |
R3445 | T7128 | T7131 | det | the,Association |
R3446 | T7129 | T7131 | compound | American,Association |
R3447 | T7130 | T7131 | compound | Rheumatism,Association |
R3448 | T7131 | T7122 | appos | Association,College |
R3449 | T7132 | T7133 | punct | ),[ |
R3450 | T7133 | T7135 | nmod | [,] |
R3451 | T7134 | T7135 | nummod | 25,] |
R3452 | T7135 | T7131 | appos | ],Association |
R3454 | T7137 | T7138 | det | All,patients |
R3455 | T7138 | T7140 | nsubj | patients,receiving |
R3456 | T7139 | T7140 | aux | were,receiving |
R3457 | T7140 | T7140 | ROOT | receiving,receiving |
R3458 | T7141 | T7140 | dobj | prednisolone,receiving |
R3459 | T7142 | T7141 | punct | (,prednisolone |
R3460 | T7143 | T7141 | appos | ≤,prednisolone |
R3461 | T7144 | T7145 | nummod | 7.5,mg/day |
R3462 | T7145 | T7143 | appos | mg/day,≤ |
R3463 | T7146 | T7145 | punct | ),mg/day |
R3464 | T7147 | T7145 | cc | and,mg/day |
R3465 | T7148 | T7150 | amod | disease-modifying,drugs |
R3466 | T7149 | T7150 | amod | antirheumatic,drugs |
R3467 | T7150 | T7145 | conj | drugs,mg/day |
R3468 | T7151 | T7140 | punct | .,receiving |
R3469 | T7152 | T7153 | amod | Clinical,parameters |
R3471 | T7154 | T7153 | prep | in,parameters |